Clinical Trial Administrator
I started at OCTO as a Clinical Trial Support Officer, with no previous experience in clinical trials; however, the position provided me with a great opportunity to start an exciting new career and develop my career skills within a motivating department. OCTO provided regular training sessions and support which enabled me to learn about all aspects of clinical trials, and after 3 years I was promoted to a Clinical Trials Administrator.
I currently work on:
NuTIDE:301: A two-part, Phase 1 open-label dose escalation and expansion study to assess safety, pharmacokinetics and clinical activity of NUC-3373, a nucleotide analogue, in participants with advanced solid tumours.
I have previously worked on:
AspECT: A Phase III, randomised study of aspirin and esomeprazole chemoprevention in Barrett's metaplasia.
CAMELLIA: A Phase I dose escalation trial of the Humanized Anti-CD47 Monoclonal Antibody Hu5F9-G4 in Haematological Malignancies